DAFNA CAPITAL MANAGEMENT LLC Viking Therapeutics, Inc. Transaction History

DAFNA CAPITAL MANAGEMENT LLC portfolio value:

$1.50M
portfolio value

DAFNA CAPITAL MANAGEMENT LLC quarter portfolio value change:

-5.88%
quarter

Viking Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +19.46% 90K shares 167K $2.72 552.4K
Q2 2022 share Increase +3.35% 15K shares -6K $2.89 462.4K
Q1 2022 share 0.00% 0 shares -716K $3 447.4K
Q4 2021 share 0.00% 0 shares -752K $4.64 447.4K
Q3 2021 share 0.00% 0 shares 130K $6.28 447.4K
Q2 2021 share 0.00% 0 shares -150K $5.99 447.4K
Q1 2021 share Decrease -1.86% -8.5K shares 263K $6.33 447.4K
Q4 2020 share Increase +1.11% 5K shares -57K $5.63 455.9K
Q3 2020 share 0.00% 0 shares -627K $5.82 450.9K
Q2 2020 share 0.00% 0 shares 1.14M $7.21 450.9K
Q1 2020 share Increase +115.54% 241.7K shares 432K $4.68 450.9K
Q4 2019 share 0.00% 0 shares 239K $8.02 209.2K
Q3 2019 share 0.00% 0 shares -297K $6.88 209.2K
Q2 2019 share Increase +16.74% 30K shares -45K $8.3 209.2K
Q1 2019 share 0.00% 0 shares 410K $9.94 179.2K
Q4 2018 share Increase 0.00% 179.2K shares 1.37M $7.65 179.2K